Jean-Luc Harousseau is Professor of Hematology at the University of Nantes in France. He has been Chairman of the French National Authority for Health (HAS) from February 2011 to January 2016 and Chair of its Economic and Public Health Evaluation Committee from February 2014 to January 2016. He headed the Department of Clinical Haematology in Nantes University Hospital for 24 years and was Director of the Cancer Center René Gauducheau in Nantes from October 2008 to January 2011. He is currently Medical and Scientific Advisor at International Myeloma Foudation.
In his previous positions, he has been a member of the Scientific Advisory Board of the French National Cancer Institute and President of the Clinical Research in Oncology National Committee from October 2008 to January 2011. He was a founding member of the Groupe Ouest-Est Leucémies Aigues et Maladies du Sang and of the Intergroupe Français du Myélome and President of this internationally renowned cooperative group from June 2009 to January 2011. Professor Harousseau is a member of the European Haematology Association, the European Group for Blood and Marrow Transplantation, the American Society of Hematology and the American Society of Clinical Oncology.
He was member of the Scientific Advisory Board for the Multiple Myeloma Research Foundation and the International Myeloma Foundation. His areas of research interest concern the therapy of acute myeloid leukemia and for the last thirty years Multiple Myeloma. He received the 2005 Waldenström Award and the 2009 Robert Kyle Award for his scientific contribution in the field of Multiple Myeloma. Professor Harousseau has contributed to more than 500 peer-reviewed publications
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)